Moderna has appointed David Jiménez as General Manager, US, effective November 21, 2022.
Jiménez is now responsible for commercial efforts in the US, reporting to Arpa Garay, Moderna's Chief Commercial Officer.
Prior to Moderna, Jiménez spent two decades at Johnson & Johnson in a variety of leadership roles in the Medical Devices, Consumer Health and Pharmaceutical sectors, across four continents. In his most recent role, Mr. Jiménez served as President for Janssen Immunology, part of the Janssen Pharmaceutical Companies of Johnson & Johnson, leading the unit's $10+ bn US Immunology franchise. He also previously led Janssen's Pulmonary Hypertension US organization, for in-market brands, including two which achieved blockbuster status under his leadership.
Jiménez is a pharmacist, with a Doctorate in Pharmacy from the University of Alcala and a Master of Business Administration from the Instituto de Empresa, both in Madrid. He also recently completed the Advance Management Program at Harvard Business School in Boston.